Advertisement Almac Completes £2 million Client Sponsored Investment Expanding Commercial Sacheting Capacity - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Integrated Drug Development Solutions

More info about

Almac Completes £2 million Client Sponsored Investment Expanding Commercial Sacheting Capacity

Almac Pharma Services have today announced the completion of a client sponsored capital investment of £2 million at the company’s commercial facilities at the group’s headquarters in Craigavon, Northern Ireland.

The new facility, at approximately five and half thousand square feet, includes dispensing and blending suites to accommodate 2.5t batches, coupled to a state of the art sachet filling and packaging line. Supporting storage and wash areas complete the new facility.

Annualised output will be in excess of 120 million sachets, split across various packed formats.

Geoff Sloan, VP Manufacturing Operations of Almac Pharma Services said: “This investment has allowed our client to quickly meet growing demand for one of their key future products. Utilising Almac’s technical and project management expertise to deliver a complex engineering solution to an aggressive project timeline will assist our client in securing the market for this strongly performing product.”

Graeme McBurney, president and MD of Almac Pharma Services said: “This level of investment demonstrates our commitment to building long term, strategic relationships with our client partners.”